Granules India Limited (BOM:532482)
India · Delayed Price · Currency is INR 573.80
+20.30 (3.67%)
At close: Mar 5, 2026
Granules India Market Cap
Granules India has a market cap or net worth of 142.19 billion as of March 5, 2026. Its market cap has increased by 6.41% in one year.
Market Cap
142.19B
Enterprise Value
154.07B
Revenue
50.92B
Ranking
n/a
PE Ratio
25.52
Stock Price
573.80
Market Cap Chart
Since February 7, 2003, Granules India's market cap has increased from 163.70M to 142.19B, an increase of 86,757.54%. That is a compound annual growth rate of 34.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 4, 2026 | 137.16B | -5.57% |
| Dec 31, 2025 | 145.25B | 1.29% |
| Dec 31, 2024 | 143.40B | 45.94% |
| Dec 29, 2023 | 98.26B | 27.40% |
| Dec 30, 2022 | 77.13B | -7.49% |
| Dec 31, 2021 | 83.37B | -4.42% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GlaxoSmithKline Pharmaceuticals | 429.60B |
| J. B. Chemicals & Pharmaceuticals | 333.18B |
| AstraZeneca Pharma India | 219.95B |
| Jubilant Pharmova | 134.45B |
| Rubicon Research | 127.42B |
| Caplin Point Laboratories | 127.32B |
| CORONA Remedies | 96.63B |
| Sanofi India | 88.93B |